MCL1 and non-small cell lung carcinoma: Recently, Lee et al. [30] demonstrated that Narciclasine reduces NSCLC spheroid viability and increases their sensitivity to cisplatin by inducing apoptosis via upregulation of NOXA expression and inhibition of MCL1 translation.